Thirty years of HIV and AIDS: future challenges and opportunities
- PMID: 21628350
- DOI: 10.7326/0003-4819-154-11-201106070-00345
Thirty years of HIV and AIDS: future challenges and opportunities
Abstract
As the third decade since AIDS was first recognized comes to an end, extraordinary advances have occurred in the understanding, treatment, and prevention of HIV infection and AIDS. As a result of these successes, it is now time to focus on future challenges. Paramount among these is reaching the goal of truly controlling and ultimately ending the HIV and AIDS pandemic. To that end, AIDS researchers and public health personnel worldwide are aggressively pursuing 3 key areas of scientific research. Given the availability of highly effective therapeutic regimens for HIV infection, the first challenge is efficiently identifying a maximum number of HIV-infected persons through voluntary HIV testing and initiating antiretroviral therapy (ART). Second, scientists are trying to develop a cure for HIV infection, which would alleviate the need for lifelong ART. Finally, preventing new cases of HIV infection, which currently number approximately 2.6 million per year globally, is critical to any attempt to end this pandemic. This article addresses each of these challenges and provides directions for the future.
Similar articles
-
Investing to meet the scientific challenges of HIV/AIDS.Health Aff (Millwood). 2009 Nov-Dec;28(6):1629-41. doi: 10.1377/hlthaff.28.6.1629. Health Aff (Millwood). 2009. PMID: 19887404
-
Thirty years into the AIDS pandemic.Med Health R I. 2011 Oct;94(10):283. Med Health R I. 2011. PMID: 22164656 No abstract available.
-
Ending the HIV/AIDS Pandemic1.Emerg Infect Dis. 2018 Mar;24(3):413-416. doi: 10.3201/eid2403.171797. Emerg Infect Dis. 2018. PMID: 29460740 Free PMC article. Review.
-
Potential of polymeric nanoparticles in AIDS treatment and prevention.Expert Opin Drug Deliv. 2011 Jan;8(1):95-112. doi: 10.1517/17425247.2011.543673. Epub 2010 Dec 13. Expert Opin Drug Deliv. 2011. PMID: 21143001 Review.
-
Toward an AIDS-free generation.JAMA. 2012 Jul 25;308(4):343-4. doi: 10.1001/jama.2012.8142. JAMA. 2012. PMID: 22820783 No abstract available.
Cited by
-
Developing strategies for HIV-1 eradication.Trends Immunol. 2012 Nov;33(11):554-62. doi: 10.1016/j.it.2012.07.001. Epub 2012 Aug 3. Trends Immunol. 2012. PMID: 22867874 Free PMC article. Review.
-
Controversies in HIV cure research.J Int AIDS Soc. 2012 Mar 16;15(1):16. doi: 10.1186/1758-2652-15-16. J Int AIDS Soc. 2012. PMID: 22424402 Free PMC article.
-
Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India.PLoS One. 2019 Mar 28;14(3):e0213911. doi: 10.1371/journal.pone.0213911. eCollection 2019. PLoS One. 2019. PMID: 30921340 Free PMC article. Clinical Trial.
-
Ageing with HIV: challenges and coping mechanisms of older adults 50 years and above living with HIV in Uganda.BMC Geriatr. 2024 Jan 24;24(1):95. doi: 10.1186/s12877-024-04704-z. BMC Geriatr. 2024. PMID: 38267880 Free PMC article.
-
Dysbiotic Fecal Microbiome in HIV-1 Infected Individuals in Ghana.Front Cell Infect Microbiol. 2021 May 18;11:646467. doi: 10.3389/fcimb.2021.646467. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34084754 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials